Lifeward (LFWD) vs InspireMD (NSPR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Lifeward (LFWD) has outperformed InspireMD (NSPR) over the past year, losing 32.2% versus a loss of 80.3%. Over five years, NSPR leads with a -88.7% price change compared with -94.3% for LFWD. InspireMD is the larger company by market cap ($22.3 million vs $18.2 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LFWD | NSPR |
|---|---|---|
| Share price | $6.43 | $0.48 |
| Market cap | $18.21M | $22.31M |
| 1-day change | -1.08% | -6.61% |
| YTD return | -6.12% | -73.03% |
| 1-year return | -32.21% | -80.33% |
| 5-year return | -94.31% | -88.68% |
| EPS (TTM) | $-15.73 | $-0.62 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.84 | $2.54 |
| 52-week low | $4.14 | $0.467 |
| Distance from 52-week high | -34.65% | -81.10% |
| Analyst consensus | none | none |
| Avg. price target upside | +211.04% | +593.75% |
| Average volume | 6.08K | 77.47K |
| Shares outstanding | 2.83M | 46.49M |
| Employees | 81 | 127 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LFWD has outperformed NSPR by 48.1 percentage points over the past year.
About Lifeward
LFWD stock →Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices for individuals with spinal cord injury; ReStore Exo-Suit, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals' post-stroke.
Healthcare · Medical Devices · 81 employees
About InspireMD
NSPR stock →InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions.
Healthcare · Medical Devices · 127 employees
LFWD vs NSPR FAQ
Which is bigger, Lifeward or InspireMD?
InspireMD (NSPR) is larger, with a market capitalization of $22.31M compared with $18.21M for Lifeward (LFWD).
Which stock has performed better over the past year, LFWD or NSPR?
LFWD returned -32.21% over the past 12 months, compared with -80.33% for NSPR (price return, excluding dividends). Past performance does not predict future results.
Are Lifeward and InspireMD in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.